Related Experiment Video
Updated: Sep 15, 2025
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Impact of Serious Infection on Mortality of Patients With Chronic Liver Disease: A Nationwide Population-based Cohort
Jae Yoon Jeong1, Ju-Yeon Cho2, Danbee Kang3
1Division of Gastroenterology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
Background & Aims:
This study aimed to investigate the impact of serious infection on mortality of patients with chronic liver disease (CLD).
Methods:
This study was conducted on 1,699,159 patients with CLD from the Korean National Health Insurance Service between 2009 and 2021. Serious infection was defined as acute meningitis, acute osteomyelitis, bacteremia, pneumonia, pyelonephritis, serious gastrointestinal infection, skin and soft tissue infections, spontaneous bacterial peritonitis, or COVID-19 infection. The primary outcome was all-cause mortality stratified by serious infection episodes (0, 1, and ≥2).
Results:
The mean age of patients was 57.4 years, with 55.6% being men. Among them, the proportion of CLD without cirrhosis, compensated cirrhosis, and decompensated cirrhosis was 77.5% (n = 1,317,468), 17.5% (n = 296,617), and 5.0% (n = 85,074), respectively. During follow-up, there were 336,602 episodes of serious infections, with pneumonia being the most common, followed by serious gastrointestinal infection, pyelonephritis, and bacteremia. Mortality rates were 3.94, 41.58, and 114.03 per 1000 person-years in patients with 0, 1, and ≥2 serious infections, respectively. Multivariable analysis indicated that adjusted hazard ratios (aHRs) for mortality were 6.04 (95% confidence interval [CI], 5.96-6.13) for 1 infection and 13.40 (95% CI, 13.20-13.60) for ≥2 infections, compared with no infections. Compared with CLD without cirrhosis, the development of serious infection was higher in compensated cirrhosis (aHR, 1.99; 95% CI, 1.97-2.02) and decompensated cirrhosis (aHR, 3.31; 95% CI, 3.26-3.37).
Conclusions:
Patients with CLD exhibited a trend of increased mortality dependent on the number of serious infections and the degree of disease severity of CLD, ranging from CLD without cirrhosis, compensated cirrhosis, and decompensated cirrhosis. Decompensated cirrhosis has more than a 3-fold risk of infection than CLD without cirrhosis.
Related Concept Videos
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:26Stages of Infection
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...